Clinical trial
Physiological Response to U-LABA/ICS With Emphasis on Exercise Performance, Vilanterol
NCT06066606 is registered in ClinicalTrials.gov with Morten Hostrup, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Physiological Response to U-LABA/ICS With Emphasis on Exercise Performance, Vilanterol
- Lead sponsor
- Morten Hostrup, PhD
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 3, 2023
- Completion date
- December 1, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
exercise performance